IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-7.92%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$443M
AUM Growth
+$443M
(-1.2%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-34.63%
Top 10 Holdings %
Top 10 Hldgs %
47.3%
Holding
81
New
8
Increased
12
Reduced
20
Closed
11
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$19.3M |
| 2 |
Novavax
NVAX
|
$18.5M |
| 3 |
Zai Lab
ZLAB
|
$8.59M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$7.65M |
| 5 |
Sanofi
SNY
|
$7.64M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$51.4M |
| 2 |
Amgen
AMGN
|
$38.1M |
| 3 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$29.3M |
| 4 |
Insmed
INSM
|
$28.8M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$25.7M |
Sector Composition
| 1 | Healthcare | 99.23% |
| 2 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kodiak Sciences
KOD
$478M
| – | – | -16,200 | Closed | -$1.37M |
|
77
Nektar Therapeutics
NKTR
$568M
| – | – | -67,000 | Closed | -$905K |
|
78
Sutro Biopharma
STRO
$72.7M
| – | – | -139,331 | Closed | -$2.07M |
|
|
ARNA
79
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – | -21,000 | Closed | -$1.95M |
|
|
ZGNX
80
DELISTED
Zogenix, Inc.
ZGNX
| – | – | -135,000 | Closed | -$2.19M |
|